Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Malykh AG, Sadaie MR.

Drugs. 2010 Feb 12;70(3):287-312. doi: 10.2165/11319230-000000000-00000. Review.

PMID:
20166767
2.
3.

Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Mbizvo GK, Dixon P, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD001901. doi: 10.1002/14651858.CD001901.pub2. Review.

PMID:
22972056
4.

Pharmacological treatments for preventing epilepsy following traumatic head injury.

Thompson K, Pohlmann-Eden B, Campbell LA, Abel H.

Cochrane Database Syst Rev. 2015 Aug 10;(8):CD009900. doi: 10.1002/14651858.CD009900.pub2. Review.

PMID:
26259048
5.

Levetiracetam: treatment in epilepsy.

Ben-Menachem E.

Expert Opin Pharmacother. 2003 Nov;4(11):2079-88. Review.

PMID:
14596661
6.

Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.

Chaisewikul R, Privitera MD, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2001;(1):CD001901. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001901.

PMID:
11279737
7.

Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.

De Smedt T, Raedt R, Vonck K, Boon P.

CNS Drug Rev. 2007 Spring;13(1):43-56. Review.

8.

Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Patsalos PN, Sander JW.

Drug Saf. 1994 Jul;11(1):37-67. Review.

PMID:
7917080
9.

Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.

De Smedt T, Raedt R, Vonck K, Boon P.

CNS Drug Rev. 2007 Spring;13(1):57-78. Review.

10.

Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.

Kaminski RM, Matagne A, Patsalos PN, Klitgaard H.

Epilepsia. 2009 Mar;50(3):387-97. doi: 10.1111/j.1528-1167.2008.01713.x. Epub 2008 Jul 8. Review.

11.

Spotlight on levetiracetam in epilepsy.

Lyseng-Williamson KA.

CNS Drugs. 2011 Oct 1;25(10):901-5. doi: 10.2165/11208340-000000000-00000. Review.

PMID:
21936590
12.

Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.

Tan HJ, Singh J, Gupta R, de Goede C.

Cochrane Database Syst Rev. 2014 Sep 5;(9):CD006779. doi: 10.1002/14651858.CD006779.pub2. Review.

PMID:
25190506
13.

Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.

Leppik IE.

J Child Neurol. 2002 Jan;17 Suppl 1:S53-7. Review.

PMID:
11918464
14.

[A pharmacological profile of piracetam (Myocalm), a drug for myoclonus].

Tajima K, Nanri M.

Nihon Yakurigaku Zasshi. 2000 Oct;116(4):209-14. Review. Japanese.

PMID:
11084917
15.
16.
17.

Using the new antiepilepsy drugs in children.

Wheless JW.

J Child Neurol. 2002 Jan;17 Suppl 1:S58-64. Review.

PMID:
11918465
18.

Piracetam and other structurally related nootropics.

Gouliaev AH, Senning A.

Brain Res Brain Res Rev. 1994 May;19(2):180-222. Review.

PMID:
8061686
19.

Preliminary efficacy of levetiracetam in monotherapy.

Ben-Menachem E.

Epileptic Disord. 2003 May;5 Suppl 1:S51-5. Review.

20.

Piracetam--an old drug with novel properties?

Winnicka K, Tomasiak M, Bielawska A.

Acta Pol Pharm. 2005 Sep-Oct;62(5):405-9. Review.

Supplemental Content

Support Center